This company is included in Intelligence Lab

Stoke Therapeutics

Stoke Therapeutics logo

Website
https://www.stoketherapeutics.com/
Founded
2014

Technologies

Antisense Oligonucleotides

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.

Articles Mentioning This Company

Antisense Oligonucleotides Make Sense

     Articles
Antisense oligonucleotides (ASOs) are short (about 12 to 25 nucleotides long), synthetic single strands of DNA or RNA that are complementary to a chosen sequence. They can alter RNA and reduce, restore, or modify protein expression. ASOs interact with proteins on the surface of cells and enter the cytoplasm. Then …